Drug Information Association Logo
Corporate Tagline

Session 9, Part II – Real World Evidence: Safety Applications

Track:
General Session

Day & Time:
January 15, 10:30AM - 12:00PM

Type:
Session

Title:
Session 9, Part II – Real World Evidence: Safety Applications

Chair(s):
Stephen Knowles, MD,MRCP
Senior Director, Global Patient Safety Medical and Benefit Risk Management.
Eli Lilly and Company, United States

Description:
Session 9, Part II – Real World Evidence: Safety Applications

Presentation(s) & Speaker(s):
Current Use of Real World Evidence of Signal Assessment
John Seeger, DrPH,PharmD
Assistant Professor
Harvard Medical School/Brigham & Women's Hospital, United States

Future of Large Databases in Data Mining
Andrew Bate, PhD,MA
Senior Director, Analytics Team Lead, WSR Epidemiology
Pfizer Inc, United Kingdom

Assessing the Effectiveness of Risk Minimization Programs: Future Needs and Opportunities for Using Real World Evidence
Gary H. Slatko, MD
Director, Office of Medication Error Prevention and Risk Management, OSE, CDER
FDA , United States